IP Library Granted Patent US 12,434,067
Granted Patent B2
US 12,434,067 · App. 18/223,727 · Granted Oct 7, 2025

Wearable cardioverter defibrillator (WCD) system computing heart rate from noisy ECG signal

Inventor: Joseph L. Sullivan (Kirkland, WA)
Assignee: West Affum Holdings DAC
A61N1/3987A61B5/0002A61B5/02438A61B5/0245A61B5/25A61B5/339A61B5/352A61B5/361A61B5/6823A61B5/7203A61N1/025A61N1/3904A61B5/0006A61B5/02028A61B5/021A61B5/02405A61B5/0261A61B5/0816A61B5/1112A61B5/14542A61B5/14551A61B5/341A61B5/364A61B5/7275A61N1/0484A61N2001/083A61N1/3968
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,434,067
App. No.
18/223,727
Granted
Oct 7, 2025
Kind
B2
Abstract

In embodiments, a WCD system includes electrodes with which it senses an ECG signal of the patient. A processor may detect sequential peaks within the ECG signal, measure durations of time intervals between the peaks, including between non-sequential peaks, and identify a representative duration that best meets a plausibility criterion. The plausibility criterion may be that the representative duration is the one that occurs the most often, i.e. is the mode. Then a heart rate can be computed from a duration indicated by the representative duration and, if the heart rate meets a shock condition, the WCD system may deliver a shock to the patient. An advantage can be that the representative duration can be close to a good R-R interval measurement of a patient, notwithstanding noise in the ECG signal that is in the shape of peaks.

Claims (74)

1. A wearable cardioverter defibrillator (WCD) system, comprising:

a support structure configured to be worn by a patient;

an energy storage module configured to store an electrical charge;

a discharge circuit coupled to the energy storage module;

a plurality of electrodes configured to be coupled with the patient's body; and

a processor configured to:

sense, with the plurality of electrodes, a first Electrocardiogram (ECG) signal of the patient in a first channel, and a second ECG signal of the patient in a second channel;

identify a first group of peaks in the first ECG signal;

measure intervals between a first number of peaks in the first group of peaks to provide a first set of intervals from the first channel;

identify a second group of peaks in the second ECG signal;

measure intervals between a second number of peaks in the second group of peaks to provide a second set of intervals from the second channel;

combine the first set of intervals from the first channel with the second set of intervals from the second channel to provide a combined group of intervals;

identify a mode interval in the combined group of intervals corresponding to a mode of the combined group of intervals, wherein the mode of the combined group of intervals comprises a most frequently occurring interval;

compute a heart rate value for the patient from the mode interval;

determine, based at least in part on the heart rate value, whether one or more shock criteria are met; and

control, responsive to the one or more shock criteria being met, the discharge circuit to discharge the stored electrical charge through the patient while the support structure is worn by the patient to deliver a therapeutic shock to the patient.

2. The WCD system of claim 1 , further comprising:

a communication module configured to wirelessly transmit heart rate to a remote device.

3. The WCD system of claim 1 , further comprising:

a user interface configured to display heart rate.

4. The WCD system of claim 1 , wherein:

the measured intervals in the first group of peaks and the second group of peaks include consecutive intervals and non-consecutive intervals.

5. The WCD system of claim 1 , wherein:

the first number of peaks comprises all of the peaks in the first group of peaks; and

the second number of peaks comprises all of the peaks in the second group of peaks.

6. The WCD system of claim 1 , wherein:

all of the intervals in the first group of peaks are measured; and

all of the intervals in the second group of peaks are measured.

7. The WCD system of claim 1 , wherein the processor is further configured to:

discern clusters of intervals in the combined group of intervals; and

wherein the mode interval is determined from a cluster that corresponds to the mode of the combined group of intervals.

8. The WCD system of claim 7 , wherein:

the clusters are discerned by filtering intervals in the combined group of intervals to identify the mode interval for the cluster.

9. The WCD system of claim 7 , wherein:

the clusters are discerned by running a grouping kernel on the intervals in the combined group of intervals to identify the node interval for the cluster.

10. The WCD system of claim 9 , wherein:

the grouping kernel is implemented as a boxcar Finite Impulse Response (FIR) filter.

11. A method for a cardiac monitoring device, the cardiac monitoring device including a processor, a memory, and electrodes, the method comprising:

sensing, by the electrodes, an Electrocardiogram (ECG) signal of a patient;

detecting, with the processor, peaks occurring within the ECG signal;

establishing pairs of the detected peaks with the processor, at least one of the pairs being established by peaks not occurring sequentially;

measuring, with the processor, durations of time intervals defined by the established pairs of the detected peaks;

identifying, with the processor and from the measured durations of time intervals, a mode duration, wherein the mode duration comprises a most common value of the measured durations of time intervals;

computing a heart rate of the patient, with the processor, from the mode duration;

storing, from the processor, the heart rate in the memory;

determining, with the processor and from the heart rate, whether an arrhythmia event is detected; and

generating a notification regarding patient status responsive to the detected arrhythmia event.

12. The method of claim 11 , wherein:

the cardiac monitoring device further includes a communication module; and

the method further comprises wirelessly transmitting the stored heart rate.

13. The method of claim 11 , wherein:

the cardiac monitoring device further includes a screen; and

the method further comprises displaying the stored heart rate on the screen.

14. The method of claim 11 , further comprising:

establishing all possible pairs of the detected peaks.

15. The method of claim 11 , further comprising:

sensing, by the electrodes, another ECG signal of the patient distinct from the ECG signal;

detecting, with the processor, other peaks occurring within the other ECG signal;

establishing, with the processor, other pairs of the detected other peaks, at least one of the other pairs being established by other peaks not occurring sequentially within the other ECG signal;

measuring, with the processor, other durations of time intervals defined by the established other pairs; and

identifying, with the processor, the mode duration from both the measured durations of time intervals and the measured other durations.

16. The method of claim 11 , wherein:

the most common value comprises a mode of the measured durations of time intervals.

17. The method of claim 11 , wherein:

a fraction of the mode duration occurs less often than an occurrence threshold.

18. The method of claim 11 , wherein:

the mode duration has a value of D and occurs M times; and

a duration having a value of D/N, where N takes one of the values of 2, 3, 4 and 5, occurs less often than M/N times.

19. The method of claim 11 , wherein:

the heart rate is computed from a duration having a number of occurrences that is one-half or one-third of a number of occurrence of the mode duration.

20. The method of claim 11 , wherein:

the cardiac monitoring device includes a support structure configured to be worn by the patient, an energy storage module storing an electrical charge, and a discharge circuit coupled to the energy storage module, and

the method further comprising:

responsive to the detected arrhythmia event, controlling, with the processor and responsive to a shock criterion being met, the discharge circuit to discharge the stored electrical charge through the patient while the support structure is worn by the patient to deliver a shock to the patient.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2025
From: PHYSIO-CONTROL DEVELOPMENT CO., LLC
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070384/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: SULLIVAN, JOSEPH L.
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 065715/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: PHYSIO-CONTROL, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 065716/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DAC
Reel/Frame 065716/0785 →
Continuity (5)
Continuation 17172859 · Feb 10, 2021
Continuation 15948884 · Apr 9, 2018
Continuation In Part 15880853 · Jan 26, 2018
Provisional Application 62501009 · May 3, 2017
Related Publication 20240001131A1 · Jan 4, 2024
References Cited (175)
US 3724455A · Unger · 1973 [cited by applicant]
US 4583524A · Hutchins · 1986 [cited by applicant]
US 4619265A · Morgan et al. · 1986 [cited by applicant]
US 4666432A · McNeish et al. · 1987 [cited by applicant]
US 4698848A · Buckley · 1987 [cited by applicant]
US 4928690A · Heilman et al. · 1990 [cited by applicant]
US 4955381A · Way et al. · 1990 [cited by applicant]
US 5078134A · Heilman et al. · 1992 [cited by applicant]
US 5228449A · Christ et al. · 1993 [cited by applicant]
US 5348008A · Bornn et al. · 1994 [cited by applicant]
US 5353793A · Bornn · 1994 [cited by applicant]
US RE34800E · Hutchins · 1994 [cited by applicant]
US 5394892A · Kenny et al. · 1995 [cited by applicant]
US 5405362A · Kramer et al. · 1995 [cited by applicant]
US 5474574A · Payne et al. · 1995 [cited by applicant]
US 5618208A · Crouse et al. · 1997 [cited by applicant]
US 5662690A · Cole et al. · 1997 [cited by applicant]
US 5708978A · Johnsrud · 1998 [cited by applicant]
US 5741306A · Glegyak et al. · 1998 [cited by applicant]
US 5782878A · Morgan et al. · 1998 [cited by applicant]
US 5792204A · Snell · 1998 [cited by applicant]
US 5902249A · Lyster · 1999 [cited by applicant]
US 5913685A · Hutchins · 1999 [cited by applicant]
US 5944669A · Kaib · 1999 [cited by applicant]
US 6047203A · Sackner et al. · 2000 [cited by applicant]
US 6065154A · Hulings et al. · 2000 [cited by applicant]
US 6108197A · Janik · 2000 [cited by applicant]
US 6148233A · Owen et al. · 2000 [cited by applicant]
US 6201992B1 · Freeman · 2001 [cited by applicant]
US 6263238B1 · Brewer et al. · 2001 [cited by applicant]
US 6280461B1 · Glegyak et al. · 2001 [cited by applicant]
US 6287328B1 · Snyder et al. · 2001 [cited by applicant]
US 6304780B1 · Owen et al. · 2001 [cited by applicant]
US 6319011B1 · Motti et al. · 2001 [cited by applicant]
US 6334070B1 · Nova et al. · 2001 [cited by applicant]
US 6356785B1 · Snyder et al. · 2002 [cited by applicant]
US 6427083B1 · Owen et al. · 2002 [cited by applicant]
US 6450942B1 · Lapanashvili et al. · 2002 [cited by applicant]
US 6529875B1 · Nakajima et al. · 2003 [cited by applicant]
US 6546285B1 · Owen et al. · 2003 [cited by applicant]
US 6671545B2 · Fincke · 2003 [cited by applicant]
US 6681003B2 · Linder et al. · 2004 [cited by applicant]
US 6762917B1 · Verbiest et al. · 2004 [cited by applicant]
US 7065401B2 · Worden · 2006 [cited by applicant]
US 7559902B2 · Ting et al. · 2009 [cited by applicant]
US 7865238B2 · Brink · 2011 [cited by applicant]
US 7870761B2 · Valentine et al. · 2011 [cited by applicant]
US 7974689B2 · Volpe et al. · 2011 [cited by applicant]
US 8135462B2 · Owen et al. · 2012 [cited by applicant]
US 8140154B2 · Donnelly et al. · 2012 [cited by applicant]
US 8369944B2 · Macho et al. · 2013 [cited by applicant]
US 8527028B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8548557B2 · Garstka et al. · 2013 [cited by applicant]
US 8560044B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8615295B2 · Savage et al. · 2013 [cited by applicant]
US 8644925B2 · Volpe et al. · 2014 [cited by applicant]
US 8676313B2 · Volpe et al. · 2014 [cited by applicant]
US 8706255B2 · Phillips et al. · 2014 [cited by applicant]
US 8742349B2 · Urbon et al. · 2014 [cited by applicant]
US 8897860B2 · Volpe et al. · 2014 [cited by applicant]
US 8904214B2 · Volpe et al. · 2014 [cited by applicant]
US 8965500B2 · Macho et al. · 2015 [cited by applicant]
US 9008801B2 · Kaib et al. · 2015 [cited by applicant]
US 9084583B2 · Mazar et al. · 2015 [cited by applicant]
US 9089685B2 · Sullivan et al. · 2015 [cited by applicant]
US 9119547B2 · Cazares et al. · 2015 [cited by applicant]
US 9131901B2 · Volpe et al. · 2015 [cited by applicant]
US 9132267B2 · Kaib · 2015 [cited by applicant]
US 9265432B2 · Warren et al. · 2016 [cited by applicant]
US 9345898B2 · Piha et al. · 2016 [cited by applicant]
US 9408548B2 · Volpe et al. · 2016 [cited by applicant]
US 9445719B2 · Libbus et al. · 2016 [cited by applicant]
US 9454219B2 · Volpe et al. · 2016 [cited by applicant]
US 9579020B2 · Libbus et al. · 2017 [cited by applicant]
US 9592403B2 · Sullivan · 2017 [cited by applicant]
US 9598799B2 · Shoshani et al. · 2017 [cited by applicant]
US 9675804B2 · Whiting et al. · 2017 [cited by applicant]
US 9724008B2 · Sullivan et al. · 2017 [cited by applicant]
US 9878171B2 · Kaib · 2018 [cited by applicant]
US 9895105B2 · Romem · 2018 [cited by applicant]
US 9901741B2 · Chapman et al. · 2018 [cited by applicant]
US RE46926E · Bly et al. · 2018 [cited by applicant]
US 10016613B2 · Kavounas · 2018 [cited by applicant]
US 10076656B2 · Dar et al. · 2018 [cited by applicant]
US 10307133B2 · Kaib · 2019 [cited by applicant]
US 10463867B2 · Kaib et al. · 2019 [cited by applicant]
US 10589110B2 · Oskin et al. · 2020 [cited by applicant]
US 10599814B2 · Andrum et al. · 2020 [cited by applicant]
US 20020181680A1 · Linder et al. · 2002 [cited by applicant]
US 20030158593A1 · Heilman et al. · 2003 [cited by applicant]
US 20050107833A1 · Freeman et al. · 2005 [cited by applicant]
US 20050107834A1 · Freeman et al. · 2005 [cited by applicant]
US 20060173499A1 · Hampton et al. · 2006 [cited by applicant]
US 20080312709A1 · Volpe et al. · 2008 [cited by applicant]
US 20090005827A1 · Weintraub et al. · 2009 [cited by applicant]
US 20100007413A1 · Herleikson et al. · 2010 [cited by applicant]
US 20100298899A1 · Donnelly et al. · 2010 [cited by applicant]
US 20110022105A9 · Owen et al. · 2011 [cited by applicant]
US 20110288604A1 · Kaib et al. · 2011 [cited by applicant]
US 20110288605A1 · Kaib et al. · 2011 [cited by applicant]
US 20120112903A1 · Kaib et al. · 2012 [cited by applicant]
US 20120144551A1 · Guldalian · 2012 [cited by applicant]
US 20120150008A1 · Kaib et al. · 2012 [cited by applicant]
US 20120158075A1 · Kaib et al. · 2012 [cited by applicant]
US 20120191476A1 · Reid et al. · 2012 [cited by applicant]
US 20120265265A1 · Razavi et al. · 2012 [cited by applicant]
US 20120283794A1 · Kaib et al. · 2012 [cited by applicant]
US 20120293323A1 · Kaib et al. · 2012 [cited by applicant]
US 20120302860A1 · Volpe et al. · 2012 [cited by applicant]
US 20120310315A1 · Savage et al. · 2012 [cited by applicant]
US 20130085538A1 · Volpe et al. · 2013 [cited by applicant]
US 20130144355A1 · Macho et al. · 2013 [cited by applicant]
US 20130231711A1 · Kaib · 2013 [cited by applicant]
US 20130245388A1 · Rafferty et al. · 2013 [cited by applicant]
US 20130274565A1 · Langer et al. · 2013 [cited by applicant]
US 20130317852A1 · Worrell et al. · 2013 [cited by applicant]
US 20130325078A1 · Whiting et al. · 2013 [cited by applicant]
US 20140012144A1 · Crone · 2014 [cited by applicant]
US 20140025131A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140046391A1 · Cowan et al. · 2014 [cited by applicant]
US 20140070957A1 · Onginotti-Buitoni et al. · 2014 [cited by applicant]
US 20140107541A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140163663A1 · Poddar et al. · 2014 [cited by applicant]
US 20140324112A1 · Macho et al. · 2014 [cited by applicant]
US 20140378812A1 · Saroka et al. · 2014 [cited by applicant]
US 20150039053A1 · Kaib et al. · 2015 [cited by applicant]
US 20150297107A1 · Sullivan et al. · 2015 [cited by applicant]
US 20150297135A1 · Shoshani et al. · 2015 [cited by applicant]
US 20150328472A1 · Sullivan · 2015 [cited by examiner]
US 20160004831A1 · Carlson et al. · 2016 [cited by applicant]
US 20160082277A1 · Foshee, Jr. et al. · 2016 [cited by applicant]
US 20160113581A1 · Amir et al. · 2016 [cited by applicant]
US 20160220832A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160243374A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160256104A1 · Romem et al. · 2016 [cited by applicant]
US 20160283900A1 · Johnson et al. · 2016 [cited by applicant]
US 20160331987A1 · Chapman et al. · 2016 [cited by applicant]
US 20170014073A1 · Shoshani et al. · 2017 [cited by applicant]
US 20170027469A1 · Amir et al. · 2017 [cited by applicant]
US 20170036066A1 · Chahine · 2017 [cited by applicant]
US 20170040758A1 · Amir et al. · 2017 [cited by applicant]
US 20170136251A1 · Sullivan · 2017 [cited by applicant]
US 20170162840A1 · Pendry · 2017 [cited by applicant]
US 20170319862A1 · Foshee, Jr. et al. · 2017 [cited by applicant]
US 20170367591A1 · Jorgenson · 2017 [cited by applicant]
US 20180116537A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180117299A1 · Gustavson et al. · 2018 [cited by applicant]
US 20180184933A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180185662A1 · Foshee, Jr. et al. · 2018 [cited by applicant]
US 20180243578A1 · Volosin · 2018 [cited by applicant]
US 20180361165A1 · Jaax et al. · 2018 [cited by applicant]
US 20190030352A1 · Sullivan et al. · 2019 [cited by applicant]
US 20190076666A1 · Medema · 2019 [cited by applicant]
US 20190116896A1 · Armour et al. · 2019 [cited by applicant]
US 20190321650A1 · Raymond et al. · 2019 [cited by applicant]
DE 102005060985A1 · 2007 [cited by applicant]
EP 2305110B1 · 2018 [cited by applicant]
JP 4320257B2 · 2009 [cited by applicant]
JP 2014526282A · 2014 [cited by applicant]
JP 5963767B2 · 2016 [cited by applicant]
WO 9839061A2 · 1998 [cited by applicant]
WO 2011146448A1 · 2011 [cited by applicant]
WO 2012064604A1 · 2012 [cited by applicant]
WO 2012151160A1 · 2012 [cited by applicant]
WO 2015056262A1 · 2015 [cited by applicant]
WO 2016077786A1 · 2016 [cited by applicant]
EP Search Report for EPO Application No. 18 170 581.5, mailed on Oct. 8, 2018. [cited by applicant]
Heartstart MRx and XL AED Algorithm—Application Note, Jul. 2001, Edition 2 Philips Healthcare, USA. [cited by applicant]
Klein, H. U., Goldenberg I., & Moss, A. J., Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update, European Heart Journal, May 31, 2… [cited by applicant]
LIFECOR LifeVest System Model WCD 3100 Operator's Manual, 2006, Pn 20B0040 Rev FI, Zoll Lifecor Corporation, Pittsburgh, PA. [cited by applicant]
LifeVest Model 4000 Patient Manual, Zoll, 2009, PN 20B0047 Rev B. [cited by applicant]
Pagan-Carlo, et al., “Encircling Overlapping Multipulse Shock Waveforms for Transthoracic Defibrillation,” JACC Journals, Dec. 1998, vol. 32 Issue 7, p. 2065-2071. [cited by applicant]
Sooyeon Suh, Stress, Anxiety, and Heart Rate Variability in Chronic Obstructive Pulmonary Disease, Dissertation, 2010, The Ohio State University, Ohio, USA. [cited by applicant]
The LifeVest Network/Patient Data Management System, Zoll, 2015, 2000503 Rev A. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2015/051726, dated May 20, 2016, European Patent Office, Rijswijk, 9 pages. [cited by applicant]